StockData
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. (CTXR) bonds

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.52−0.01 (-1.67%)

Close on Nov 17, 2026Market cap $14.24MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$306.41M
$300.00M due within a year
Net debt
$289.40M
After $17.01M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
-143.9×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Notes and loans outstanding

As tagged in Citius Pharmaceuticals's 10-Q for the period ended Jun 30, 2026

Citius Pharmaceuticals's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
Loan Agreement$25.00M

See a number that looks wrong?